| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $50.45B | +9.3% |
| Cost of Revenue | $43.85B | +17.2% |
| R&D Expense | $124.0M | +0.0% |
| SG&A Expense | $1.31B | +4.4% |
| Operating Income | $5.10B | -24.7% |
| Interest Expense | $287.0M | -44.7% |
| Pre-tax Income | $4.78B | -29.6% |
| Income Tax | $882.0M | -24.2% |
| Net Income | $3.89B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.15B | +46.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $3.39B | -25.7% |
| Inventory | $4.80B | -2.0% |
| Current Assets | $11.85B | -3.0% |
| Total Assets | $36.37B | -1.0% |
| Current Liabilities | $6.76B | -6.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.12B | -20.5% |
| Capital Expenditures | $1.89B | -3.5% |
| Investing Cash Flow | -$1.98B | -31.6% |
| Financing Cash Flow | -$3.41B | +46.6% |
| Free Cash Flow | $4.23B | -26.3% |
| -30.8% |
| EPS (Basic) | $11.84 | -29.4% |
| EPS (Diluted) | $11.81 | -29.5% |
| Long-term Debt |
| $10.54B |
| -6.3% |
| Stockholders' Equity | $12.62B | +6.4% |